Company Intelligent Bio Solutions Inc.

Equities

INBS

US36151G6008

Biotechnology & Medical Research

End-of-day quote Nasdaq 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
2.34 USD -2.09% Intraday chart for Intelligent Bio Solutions Inc. 0.00% -42.29%

Business Summary

Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.

Number of employees: 51

Sales per Business

USD in Million2022Weight2023Weight Delta
Intelligent Fingerprinting Products
100.0 %
- - 1 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United Kingdom
84.4 %
-- 1 84.4 % -
Other
15.1 %
-- 0 15.1 % -
Australia
0.5 %
-- 0 0.5 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 56 17-08-31
Chairman 67 20-06-30
Director of Finance/CFO 63 19-03-31
Chief Operating Officer 42 18-06-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 86 20-07-31
Chief Executive Officer 56 17-08-31
Director/Board Member 54 18-03-31
Chief Operating Officer 42 18-06-30
Director/Board Member 38 20-07-31
Chairman 67 20-06-30
Director/Board Member 51 22-10-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 2,913,799 0 0 98.54 %
Stock B 1 3,117,165 3,071,690 ( 98.54 %) 116 ( 0.003721 %)

Shareholders

NameEquities%Valuation
Alyeska Investment Group LP
7.250 %
206,199 7.250 % 509 312 $
Adar1 Capital Management LLC
3.806 %
108,250 3.806 % 267 378 $
CVI Holdings LLC
3.806 %
108,250 3.806 % 267 378 $
Hudson Bay Capital Management LP
3.806 %
108,250 3.806 % 267 378 $
19,494 0.6854 % 48 150 $
Vanguard Group, Inc. (Subfiler)
0.5444 %
15,485 0.5444 % 38 248 $
Citadel Securities GP LLC
0.5218 %
14,842 0.5218 % 36 660 $
Geode Capital Management LLC
0.5036 %
14,323 0.5036 % 35 378 $
Citigroup Global Markets, Inc. (Investment Management)
0.2799 %
7,960 0.2799 % 19 661 $
Tower Research Capital LLC
0.0369 %
1,050 0.0369 % 2 594 $

Company contact information

Intelligent Bio Solutions, Inc.

142 West 57th Street

10019, New York

+(646) 828-8258

http://ibs.inc
address Intelligent Bio Solutions Inc.(INBS)
  1. Stock Market
  2. Equities
  3. INBS Stock
  4. Company Intelligent Bio Solutions Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW